tiprankstipranks

Twist Bioscience price target raised to $26 from $20 at Barclays

Barclays analyst Luke Sergott raised the firm’s price target on Twist Bioscience to $26 from $20 and keeps an Overweight rating on the shares. The company reported a “clean beat-and-raise quarter” with modest growth on the core business bookings, continued sales strength, and gross margins “going in the right direction,” the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on TWST:

Disclaimer & DisclosureReport an Issue